Adelson Research Foundation Supports 3-Year Myeloma Funding Initiative
The Dr. Miriam and Sheldon G. Adelson Medical…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe Dr. Miriam and Sheldon G. Adelson Medical…
A combination treatment including Pomalyst (pomalidomide) significantly extended the…
PT-112, an investigational small molecule that promotes cancer cell…
Some 68 percent of Canadians would feel helpless if…
Multiple myeloma patients in the United…
In an era of new therapies with unprecedented efficacy, high-dose…